Chrysanthi Ainali

St. John's Institute Of Dermatology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Human skin CD141+ dendritic cells regulate cutaneous immunity via the neuropeptide urocortin 2.

Human skin CD141+ dendritic cells regulate cutaneous immunity via the neuropeptide urocortin 2.

Journal: iScience

Published: November 20, 2022

Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Journal: Nature communications

Published: December 17, 2021

Transcriptomic profiling of recessive dystrophic epidermolysis bullosa wounded skin highlights drug repurposing opportunities to improve wound healing.

Transcriptomic profiling of recessive dystrophic epidermolysis bullosa wounded skin highlights drug repurposing opportunities to improve wound healing.

Journal: Experimental dermatology

Published: May 14, 2021

Transcriptomic Analysis of Blaschko-Linear Psoriasis Reveals Shared and Distinct Features with Psoriasis Vulgaris.

Transcriptomic Analysis of Blaschko-Linear Psoriasis Reveals Shared and Distinct Features with Psoriasis Vulgaris.

Journal: The Journal of investigative dermatology

Published: December 03, 2020

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Journal: Nature communications

Published: October 19, 2020

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling.

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling.

Journal: Cancers

Published: May 27, 2020

Single-cell mutation analysis of clonal evolution in myeloid malignancies.

Single-cell mutation analysis of clonal evolution in myeloid malignancies.

Journal: Nature

Published: January 26, 2020

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.

Journal: Journal of the American Academy of Dermatology

Published: July 02, 2019

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Journal: Nature communications

Published: August 01, 2018

Time Series Integrative Analysis of RNA Sequencing and MicroRNA Expression Data Reveals Key Biologic Wound Healing Pathways in Keloid-Prone Individuals.

Time Series Integrative Analysis of RNA Sequencing and MicroRNA Expression Data Reveals Key Biologic Wound Healing Pathways in Keloid-Prone Individuals.

Journal: The Journal of investigative dermatology

Published: March 22, 2018

Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia.

Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia.

Journal: The Journal of investigative dermatology

Published: April 18, 2017

Aptamer selection by direct microfluidic recovery and surface plasmon resonance evaluation.

Aptamer selection by direct microfluidic recovery and surface plasmon resonance evaluation.

Journal: Biosensors & bioelectronics

Published: November 18, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026